Women’s health Archives - Drugs in Context

Health-related quality of life and clinical complexity of a real-life cohort of patients with advanced HR+/HER2– breast cancer treated with CDK4/6 inhibitors and endocrine therapy

Barbara Tagliaferri, Ludovica Mollica, Raffella Palumbo, Claudia Leli, Alberto Malovini, Matteo Terzaghi, Erica Quaquarini, Cristina Teragni, Stefano Maccarone, Andrea Premoli, Federico Sottotetti

Article Type

Original Research

Published

20 Jun 2023

This real-life study investigated the link between clinical complexity and quality of life of patients with HR+/HER2– advanced breast cancer treated with CDK4/6 inhibitors.

Diabetes: how to manage gestational diabetes mellitus

S Mimi Mukherjee, Aimee Dawson

Article Type

Review

Published

14 Jun 2022

This narrative review summarizes the current state of information available regarding the treatment of gestational diabetes mellitus.

Satisfaction and usability of the recombinant chorionic gonadotropin prefilled pen: a survey in Italy

Chiara Dallagiovanna, Laura Mensi, Luca Di Gesaro, Irene La Vecchia, Marco Reschini

Article Type

Original Research

Published

26 Jan 2022

This study investigated the ease of administration and satisfaction with the human chorionic gonadotropin in a prefilled pen amongst patients and healthcare professionals.

Experience with nutraceutical supplements in the treatment of pelvic pain in gynaecology: case reports

Francisco Nohales Alfonso

Article Type

Case Report

Published

12 Jan 2022

This article examines three cases of pelvic pain, in each case clinical investigations were conducted and a multimodal approach to therapy was introduced. Nutraceutical supplement lead to pelvic pain and associated dyspareunia being largely resolved.

A review of conventional and sustained-release formulations of oral natural micronized progesterone in obstetric indications

Girija Narendrakumar Wagh, KM Kundavi Shankar, Sumitra Bachani

Article Type

Review

Published

13 Oct 2021

This narrative review examines the available evidence for oral natural micronized progesterone (NMP) and sustained-release formulation of NMP (NMP-SR) in several obstetric indications of interest.